We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mass Spec Technology Drives Innovation Across the Biopharma Workflow

Article   Sep 23, 2016

 
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
 
 
 

RELATED ARTICLES

A (Lab)Step Towards Reproducible Science

Article

The reproducibility crisis is holding back science. London-based Labstep, a start-up out of Oxford University, think that their tool can help make science more open and reproducible. That claim has now been given some concrete evidence with the announcement that the research contingent of the MRC Unit The Gambia at LSHTM will be trialling Labstep across their Banjul-based facility.

READ MORE

Discovering Druggable Targets

Article

We recently spoke to Dr Kilian V. M. Huber from the Structural Genomics Consortium & Target Discovery Institute, University of Oxford to find out – ‘What makes a good target?’.

READ MORE

Target Identification & Validation in Drug Discovery

Article

This article highlights the properties of an attractive drug target, outlines the approaches used to identify targets, and discusses the key steps involved in target validation and the benefits and challenges of using siRNA to validate targets.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE